Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for hypercalcemia in primary hyperparathyroidism patients unable to undergo parathyroidectomy
2009-012943-41Phase 3Completed
- Sponsor
- Amgen
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary hyperparathyroidism (PHPT) and hypercalcemia comparing Cinacalcet with Placebo (2 arms). Primary endpoint: Mean corrected total serum calcium normalization. Started Dec 2009; status: completed.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)hypercalcemia
Beyond the preview
Go deeper on 2009-012943-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012943-41.